Valiant Laboratories Limited has informed the Exchange regarding 'Draft Letter Of Offer For Proposed Rights Issue Of Equity Shares'.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Laboratories Limited has filed the Draft Letter of Offer dated July 09, 2025 for a proposed Rights Issue of fully paid-up equity shares with a face value of Rs. 10 each. The total issue size will not exceed Rs. 8,146.88 lakhs (approximately Rs. 81.47 crore), assuming full subscription. The issue price, ratio, and record date are yet to be finalised and will be notified later by the Rights Issue Committee. Eligible equity shareholders as on the record date will be entitled to subscribe, with 100% of the issue price payable on application. The company operates in the chemicals/API space, with promoters including Santosh Shantilal Vora, Shantilal Shivji Vora, and Dhanvallabh Ventures LLP. MUFG Intime India is the registrar and HSBC is the banker to the issue.
Existing shareholders will get an opportunity to maintain their stake by subscribing to their rights entitlement, though the stock may see some short-term dilution pressure once the record date and ratio are announced. The size of the issue (about Rs. 81.47 crore) is meaningful relative to the company's scale and could be dilutive depending on the final pricing.